PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Lundsgaard, A.M.* ; Fritzen, A.M.* ; Nicolaisen, T.S.* ; Carl, C.S.* ; Sjøberg, K.A.* ; Raun, S.H.* ; Klein, A.B.* ; Sánchez Quant, E.S. ; Langer, J. ; Ørskov, C.* ; Clemmensen, C.* ; Tschöp, M.H. ; Richter, E.A.* ; Kiens, B.* ; Kleinert, M.

Glucometabolic consequences of acute and prolonged inhibition of fatty acid oxidation.

J. Lipid Res. 61, 10-19 (2020)
Verlagsversion Preprint DOI PMC
Open Access Hybrid
Excessive circulating FAs have been proposed to promote insulin resistance (IR) of glucose metabolism by increasing the oxidation of FAs over glucose. Therefore, inhibition of FA oxidation (FAOX) has been suggested to ameliorate IR. However, prolonged inhibition of FAOX would presumably cause lipid accumulation and thereby promote lipotoxicity. To understand the glycemic consequences of acute and prolonged FAOX inhibition, we treated mice with the carnitine palmitoyltransferase 1 (CPT-1) inhibitor, etomoxir (eto), in combination with short-term 45% high fat diet feeding to increase FA availability. Eto acutely increased glucose oxidation and peripheral glucose disposal, and lowered circulating glucose, but this was associated with increased circulating FAs and triacylglycerol accumulation in the liver and heart within hours. Several days of FAOX inhibition by daily eto administration induced hepatic steatosis and glucose intolerance, specific to CPT-1 inhibition by eto. Lower whole-body insulin sensitivity was accompanied by reduction in brown adipose tissue (BAT) uncoupling protein 1 (UCP1) protein content, diminished BAT glucose clearance, and increased hepatic glucose production. Collectively, these data suggest that pharmacological inhibition of FAOX is not a viable strategy to treat IR, and that sufficient rates of FAOX are required for maintaining liver and BAT metabolic function.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
4.483
1.225
11
12
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Brown Adipose Tissue ; Carnitine Palmitoyltransferase 1 ; Hepatic Glucose Production ; Hyperglycemia ; Insulin Resistance ; Lipotoxicity ; Liver ; Mitochondrial Long-chain Fatty Acid Import; Alleviates Insulin-resistance; Skeletal-muscle; Adipose-tissue; Substrate Oxidation; Etomoxir; Metabolism; Obesity; Thermogenesis; Contribute; Lipolysis
Sprache englisch
Veröffentlichungsjahr 2020
Prepublished im Jahr 2019
HGF-Berichtsjahr 2019
ISSN (print) / ISBN 0022-2275
e-ISSN 1539-7262
Zeitschrift Journal of Lipid Research
Quellenangaben Band: 61, Heft: 1, Seiten: 10-19 Artikelnummer: , Supplement: ,
Verlag American Society for Biochemistry and Molecular Biology
Verlagsort 9650 Rockville Pike, Bethesda, Md 20814-3996 Usa
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Diabetes and Obesity (IDO)
POF Topic(s) 30201 - Metabolic Health
Forschungsfeld(er) Helmholtz Diabetes Center
PSP-Element(e) G-502200-001
DOI 10.1194/jlr.RA119000177
WOS ID WOS:000504723200002
Scopus ID 85077401639
PubMed ID 31719103
Erfassungsdatum 2020-01-09
[➜Korrektur melden]